Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
Under an Elsevier user license
open archive
Keywords
Breast cancer
costs
early stage breast cancer
economics
gene assay
molecular classifier
Oncotype DX
Cited by (0)
Copyright © 2010 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.